
|Articles|February 6, 2020
PPD Goes Public
Advertisement
Last month, PPD announced its plans to go public-the second time in its existence-filing its IPO for stock in January. Today, it began trading as PPD at $27 a share on the NASDAQ. PPD was founded in 1985 by Fred Eshelman, who took the company public in 1996. In 2011, it went private again with its
For more information, click
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Breaking the Efficacy Ceiling in IBD and Beyond
2
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
3
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
4
ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment
5




